Resmed Q1 2026 Results: Net Income $418M, Up 20.0% YoY
ResMed Inc. reported a net revenue increase to $1.41 billion for the quarter ended September 30, 2026, compared to $1.34 billion in the prior year, driven by Sleep and Breathing Health products. Net income rose to $418.4 million, significantly aided by a $61.8 million gain from the divestment of subsidiaries.
- Key figure
- Net income $418M · +20.0% YoY